Leerink upgraded Twist Bioscience (TWST) to Outperform from Market Perform with a $70 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TWST:
- Twist Bioscience Charts Profitable Path Amid Strong Growth
- Twist Bioscience price target raised to $65 from $55 at Barclays
- Midday Fly By: GameStop offers to buy eBay, Norwegian reports mixed Q1
- Twist Bioscience sees Q3 revenue $114M-$115M, consensus $111.27M
- Twist Bioscience expects to achieve adjusted EBITDA breakeven for Q4